Cervical cancer has historically been a significant public health issue worldwide, causing substantial morbidity and mortality among women. Over recent decades, advances in screening, vaccination, and ...

Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...

Liquid-based cytology is a commonly used method for cervical cancer screening, but new evidence suggests that ThinPrep, a liquid-based test, is no more effective than conventional cytology. In a ...

Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...

Gls-010, a novel anti-PD-1 mAb in Chinese patients with recurrent or metastatic cervical cancer: Results from a multicenter, open-label and single-arm phase II trial. This is an ASCO Meeting Abstract ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The risk of ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women ages 24 to ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...

As digital pathology continues to advance into the field of cytopathology, laboratories are exploring alternatives to traditional manual microscopy screening. CorePlus evaluated the performance of the ...

Preoperative geriatric assessment (GA) and surgical outcomes in older women with gynecological (gyn) cancer. Validation of the predictive value of modeled HCG residual production “P” in low-risk ...